Phase I radiation dose-escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDR-G) for unresectable pancreatic cancer
Year: 2009
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: E. Ben-Josef, K. Griffith, I. R. Francis, G. Khan, T. S. Lawrence, R. Abrams, W. Leslie, M. Zalupski
Institutions: Rush University Medical Center, University of Michigan
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2525273449
